Frontiers An overview of agents and treatments for PDGFRA

lt;p>Platelet-derived growth factor receptor A (PDGFRA) mutations occur in approximately 10–15% of gastrointestinal stromal tumors (GISTs). These tumors with P

The “SEED” Study: The Feasibility of Selecting Patient-Specific Biologically Targeted Therapy with Sorafenib, Everolimus, Erlotinib or Dasatinib for Pediatric and Young Adult Patients with Recurrent or Refractory Brain Tumors

Location and frequency of primary mutations in KIT and PDGFRA.

Frontiers New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions

Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review - ScienceDirect

The myocardium utilizes a platelet-derived growth factor receptor alpha ( Pdgfra)–phosphoinositide 3-kinase (PI3K) signaling cascade to steer toward the midline during zebrafish heart tube formation

PDF) Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor

Cancers, Free Full-Text

Ripretinib for the treatment of advanced gastrointestinal stromal tumor - John R. Zalcberg, 2021

IJMS, Free Full-Text